Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Moodys
McKesson
AstraZeneca
Dow
Mallinckrodt

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Lomustine - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for lomustine and what is the scope of patent protection?

Lomustine is the generic ingredient in one branded drug marketed by Corden Pharma and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for lomustine. One supplier is listed for this compound.

Recent Clinical Trials for lomustine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Emory UniversityPhase 2
Theodore S. JohnsonPhase 2
Global Coalition for Adaptive ResearchPhase 2/Phase 3

See all lomustine clinical trials

Pharmacology for lomustine
Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity
Medical Subject Heading (MeSH) Categories for lomustine
Synonyms for lomustine
(Chloro-2-ethyl)-1-cyclohexyl-3-nitrosourea
(Cloro-2-etil)-1-cicloesil-3-nitrosourea
(Cloro-2-etil)-1-cicloesil-3-nitrosourea [Italian]
010L474
1-(2-Chloroethyl)-1-[(cyclohexylamino)carbonyl]-2-oxohydrazine #
1-(2-chloroethyl)-3-cyclohexyl-1-nitroso-ure
1-(2-chloroethyl)-3-cyclohexyl-1-nitroso-urea
1-(2-chloroethyl)-3-cyclohexyl-1-nitrosoure
1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea
1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea [Chloroethyl nitrosoureas]
1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea1-(2-chloroethyl)-3-cyclohexyl-1-nitroso-urea13010-47-4NCI60_0417431-(2-Chloroethyl)-3-cyclohexylnitrosourea1-Nitrosourea, 1-(2-chloroethyl)-3-cyclohexyl-Be
1-(2-Chloroethyl)-3-cyclohexylnitrosourea
1-Nitrosourea, 1-(2-chloroethyl)-3-cyclohexyl-
13010-47-4
2-chloro-N-(cyclohexyl-C-hydroxycarbonimidoyl)-N-nitrosoethan-1-amine
3-(2-chloroethyl)-1-cyclohexyl-3-nitrosourea
4CH-007422
7BRF0Z81KG
A-2090
A806019
AB0013165
AB00173884_05
AB00173884_06
AB00173884-02
AB00173884-03
AB00173884-04
AB2000326
AC-8062
AC1L1H2T
ACN-048517
AI3-52779
AJ-45774
AKOS005766022
AM20070540
AN-8352
API0003206
BCP06551
Belustine
BR-72901
BRN 2125058
C-13733
C07079
C9H16ClN3O2
CAS-13010-47-4
CC-30028
CCG-213022
CCNU
CCNU [Chloroethyl nitrosoureas]
CCNU;CeeNU
CCRIS 860
Cecenu
CeeNU
CeeNU (TN)
CHEBI:6520
CHEMBL514
Chloroethylcyclohexylnitrosourea
CINU
CJ-10790
CS-1461
Cyclohexyl chloroethyl nitrosourea
D00363
DB-017097
DB01206
DS-1269
DSSTox_CID_3222
DSSTox_GSID_23222
DSSTox_RID_76930
DTXSID2023222
EINECS 235-859-2
FT-0083566
FT-0627972
Gleostine
GQYIWUVLTXOXAJ-UHFFFAOYSA-N
GTPL7214
H651
HMS2090A17
HMS3655I16
HSDB 6519
HY-13669
I06-0087
ICIG 1109
KB-146511
L0251
Lomustina
Lomustina [INN-Spanish]
Lomustine (CeeNU)
Lomustine (USAN/INN)
Lomustine [USAN:BAN:INN]
Lomustine [USAN:INN:BAN]
Lomustine, >=98%
Lomustine, European Pharmacopoeia (EP) Reference Standard
Lomustine, United States Pharmacopeia (USP) Reference Standard
Lomustinum
Lomustinum [INN-Latin]
LS-728
MolPort-001-768-818
N-(2-Chloroethyl)-N'-cyclohexyl-N-nitrosourea
NCGC00167466-01
NCGC00167466-02
NCGC00167466-03
NCI-C04740
NCI60_041743
NCIMech_000220
NPFAPI-06
NSC 79037
NSC-759635
NSC-79037
NSC759635
NSC79037
Pharmakon1600-01502301
RB 1509
s1840
SC-12119
SCHEMBL3995
SR-05000001497
SR-05000001497-1
SR-05000001497-3
SRI 2200
ST24026836
SW220040-1
TA-01004
Tox21_112470
Tox21_112470_1
UNII-7BRF0Z81KG
Urea, 1-(2-chloroethyl)-3-cyclohexyl-1-nitroso-
Urea, 1-(2-chloroethyl)-3-cyclohexyl)-1-nitroso-
Urea, N-(2-chloroethyl)-N'-cyclohexyl-N-nitroso-
W-108355
WLN: L6TJ AMVNNO&2G
ZINC3831006
ZX-AT016332

US Patents and Regulatory Information for lomustine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Corden Pharma GLEOSTINE lomustine CAPSULE;ORAL 017588-001 Approved Prior to Jan 1, 1982 RX Yes No   Start Trial   Start Trial   Start Trial
Corden Pharma GLEOSTINE lomustine CAPSULE;ORAL 017588-002 Approved Prior to Jan 1, 1982 RX Yes No   Start Trial   Start Trial   Start Trial
Corden Pharma GLEOSTINE lomustine CAPSULE;ORAL 017588-004 Dec 19, 2014 DISCN Yes No   Start Trial   Start Trial   Start Trial
Corden Pharma GLEOSTINE lomustine CAPSULE;ORAL 017588-003 Approved Prior to Jan 1, 1982 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
McKesson
Medtronic
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.